IMU 0.00% 5.0¢ imugene limited

Why IMU is a multi multi bagger, page-25942

  1. 1,165 Posts.
    lightbulb Created with Sketch. 862
    IMO, Imugene's likely data presentation conferences before end of January 2025.
    November, December or January look to be the most likely months for the long awaited US Nasdaq listing.

    Society for Immunotherapy of Cancer (SITC)
    Save the date taking place from 06 until 10 November 2024 in Houston,Texas.
    Regular Abstracts Oct. 4, 2024
    Title & Author Information Released at 9 a.m. EDT Nov. 5, 2024
    Embargo Lifted made public at 8 a.m. CST/ 9 a.m. EST. All accepted abstracts are available in the JITC

    Supplement Late-Breaking Abstracts Clinical Only (LBA),12 Sept 2024 submission site closes.Oct. 30, 2024 LBA Title & Author Information Released.Nov. 5, 2024
    Embargo Lifted & LBA Made Public at 8 a.m. CST/9 a.m. EST. All accepted abstracts are available in the JITC

    https://www.sitcancer.org/2024/schedule/sitc24-annualmeeting

    66th American Society of Hematology (ASH) Annual Meeting
    Save the date taking place from 7 until 10 December 2024 in San Diego.
    Abstract submission deadline August 1, 2024
    Abstracts available online November 5, 2024

    Call for late-breaking abstract submissions October 16-28, 2024
    Late-breaking abstracts available online November 25, 2024

    https://www.hematology.org/meetings/annual-meeting/abstracts

    ESMO Immuno-Oncology Congress 2024
    Save the date taking place from 11 until 13 December 2024 in Geneva, Switzerland.
    Abstracts Trial in Progress, Intent to submit LBA, 1 October 2024
    Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by end-October 2024.

    Late-breaking abstracts (LBA) 6 November 2024, A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline 1 October 2024.
    Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by mid-Nov 2024.

    https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2024/abstracts


    2025 ASCO Gastrointestinal Cancers Symposium
    Save the date taking place from 23 until 25 January 2025 San Francisco.
    Abstract Submission Deadline: September 24, 2024
    Abstracts accepted will be released at 5:00 PM ET on January 21, 2025.

    Late-Breaking Abstract Submission Deadline: October 24, 2024
    Late-Breaking Abstracts (LBAs) will be released at 7:00 AM (PT) on their day of presentation at the Symposium.

    https://conferences.asco.org/gi/abstracts

    Regards.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.